A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
Clinical trial NCT06982846 · COMPLETED
Trial details
- NCT number
- NCT06982846
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2026-05-04
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.